1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.

https://doi.org/10.3322/caac.21834

PMid:38572751 

2. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2023;9:4.

https://doi.org/10.1038/s41572-023-00418-5

PMid:36658129 

3. Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16:669-83.

https://doi.org/10.1038/s41571-019-0227-z

PMid:31189965 

4. Li CX, Sun JL, Gong ZC, Liu H, Ding MC, Zhao HR. An umbrella review exploring the effect of radiotherapy for head and neck cancer patients on the frequency of jaws osteoradionecrosis. Cancer Radiother. 2023;27:434-46.

https://doi.org/10.1016/j.canrad.2023.01.009

PMid:37268457 

5. Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: A national-based cohort study. Head Neck. 2017;39:1313-21.

https://doi.org/10.1002/hed.24761

PMid:28370713 

6. Acharya S, Pai KM, Acharya S. Risk assessment for osteoradionecrosis of the jaws in patients with head and neck cancer. Med Pharm Rep. 2020;93:195-9.

https://doi.org/10.15386/mpr-1418

PMid:32478327 PMCid:PMC7243884

7. Kubota H, Miyawaki D, Mukumoto N, Ishihara T, Matsumura M, Hasegawa T, et al. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol. 2021;16:1.

https://doi.org/10.1186/s13014-020-01701-5

PMid:33402192 PMCid:PMC7786900

8. Li C, Li M, Wei W, Wang Z, Yu J, Gong Z. Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China. BMC Cancer. 2024;24:534.

https://doi.org/10.1186/s12885-024-12300-y

PMid:38671413 PMCid:PMC11055382

9. Miyamoto I, Tanaka R, Kogi S, Yamaya G, Kawai T, Ohashi Y, et al. Clinical Diagnostic Imaging Study of Osteoradionecrosis of the Jaw: A Retrospective Study. J Clin Med. 2021;10:4704.

https://doi.org/10.3390/jcm10204704

PMid:34682827 PMCid:PMC8538245

10. Støre G, Boysen M. Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol Allied Sci. 2000;25:378-84.

https://doi.org/10.1046/j.1365-2273.2000.00367.x

PMid:11012651 

11. Singh A, Kitpanit S, Neal B, Yorke E, White C, Yom SK, et al. Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2023;149:151-9.

https://doi.org/10.1001/jamaoto.2022.4165

PMid:36547968 PMCid:PMC9912132

12. Beyene RT, Derryberry SL Jr, Barbul A. The Effect of Comorbidities on Wound Healing. Surg Clin North Am. 2020;100:695-705.

https://doi.org/10.1016/j.suc.2020.05.002

PMid:32681870 

13. Topkan E, Somay E, Yilmaz B, Pehlivan B, Selek U. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients. BMC Cancer. 2023;23:651.

https://doi.org/10.1186/s12885-023-11155-z

PMid:37438683 PMCid:PMC10337124

14. Thorn JJ, Hansen HS, Specht L, Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 2000;58:1088-93; discussion 1093-5.

https://doi.org/10.1053/joms.2000.9562

PMid:11021701 

15. Kuhnt T, Stang A, Wienke A, Vordermark D, Schweyen R, Hey J. Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. Radiat Oncol. 2016;11:101.

https://doi.org/10.1186/s13014-016-0679-6

PMid:27473433 PMCid:PMC4967325

16. Chen JA, Wang CC, Wong YK, Wang CP, Jiang RS, Lin JC, et al. Osteoradionecrosis of mandible bone in patients with oral cancer--associated factors and treatment outcomes. Head Neck. 2016;38:762-8.

https://doi.org/10.1002/hed.23949

PMid:25521838 

17. Shokri T, Wang W, Vincent A, Cohn JE, Kadakia S, Ducic Y. Osteoradionecrosis of the Maxilla: Conservative Management and Reconstructive Considerations. Semin Plast Surg. 2020;34:106-13.

https://doi.org/10.1055/s-0040-1709144

PMid:32390778 PMCid:PMC7202910

18. Dholam KP, Sharma MR, Gurav SV, Singh GP, Sadashiva KM, Laskar SG. Osteoradionecrosis of the jaws: A retrospective cohort study. J Cancer Res Ther. 2022;18:1016-22.

https://doi.org/10.4103/jcrt.JCRT_248_20

PMid:36149155 

19. Koga DH, Salvajoli JV, Alves FA. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis. 2008;14:40-4.

https://doi.org/10.1111/j.1601-0825.2006.01351.x

PMid:18173447 

20. Beech NM, Porceddu S, Batstone MD. Radiotherapy-associated dental extractions and osteoradionecrosis. Head Neck. 2017;39:128-32.

https://doi.org/10.1002/hed.24553

PMid:27473832 

21. Khoo SC, Nabil S, Fauzi AA, Yunus SSM, Ngeow WC, Ramli R. Predictors of osteoradionecrosis following irradiated tooth extraction. Radiat Oncol. 2021;16:130.

https://doi.org/10.1186/s13014-021-01851-0

PMid:34261515 PMCid:PMC8278595

22. Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2017;64:44-51.

https://doi.org/10.1016/j.oraloncology.2016.11.015

PMid:28024723 PMCid:PMC5560021

23. MD Anderson Head and Neck Cancer Symptom Working Group. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison. Radiother Oncol. 2017;124:232-9.

https://doi.org/10.1016/j.radonc.2017.06.026

PMid:28733053 PMCid:PMC5572506

24. Xu J, Zheng Z, Fang D, Gao R, Liu Y, Fan ZP, et al. Early-stage pathogenic sequence of jaw osteoradionecrosis in vivo. J Dent Res. 2012;91:702-8.

https://doi.org/10.1177/0022034512448661

PMid:22592127 

25. Shaw RJ, Butterworth CJ, Silcocks P, Tesfaye BT, Bickerstaff M, Jackson R, et al. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar Surgery. Int J Radiat Oncol Biol Phys. 2019;104:530-9.

https://doi.org/10.1016/j.ijrobp.2019.02.044

PMid:30851351 

26. Oh HK, Chambers MS, Martin JW, Lim HJ, Park HJ. Osteoradionecrosis of the mandible: treatment outcomes and factors influencing the progress of osteoradionecrosis. J Oral Maxillofac Surg. 2009;67:1378-86.

https://doi.org/10.1016/j.joms.2009.02.008

PMid:19531406 

27. Santos DO, Costa ARGF, Duarte PVS, Pitorro TEA, Fonseca LC, Cardoso SV, et al. Depth of invasion of oral squamous cell carcinoma in Nos2-knockout mice correlated to alterations in systemic inflammatory markers following 4NQO treatment. J Oral Pathol Med. 2024;53:208-16.

https://doi.org/10.1111/jop.13523

PMid:38418292